Page last updated: 2024-09-05

organophosphonates and kn 93

organophosphonates has been researched along with kn 93 in 1 studies

Compound Research Comparison

Studies
(organophosphonates)
Trials
(organophosphonates)
Recent Studies (post-2010)
(organophosphonates)
Studies
(kn 93)
Trials
(kn 93)
Recent Studies (post-2010) (kn 93)
9,9688803,5964990181

Protein Interaction Comparison

ProteinTaxonomyorganophosphonates (IC50)kn 93 (IC50)
Calcium/calmodulin-dependent protein kinase type II subunit betaRattus norvegicus (Norway rat)8.4
Calcium/calmodulin-dependent protein kinase type II subunit alphaRattus norvegicus (Norway rat)8.4
Calcium/calmodulin-dependent protein kinase type II subunit gammaRattus norvegicus (Norway rat)8.4
Myosin light chain kinase, smooth muscleGallus gallus (chicken)9.8
Calcium/calmodulin-dependent protein kinase type II subunit deltaRattus norvegicus (Norway rat)8.4

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akhtar, S; Benter, IF; Canatan, H; Yousif, MH1

Other Studies

1 other study(ies) available for organophosphonates and kn 93

ArticleYear
Inhibition of Ca2+/calmodulin-dependent protein kinase II, RAS-GTPase and 20-hydroxyeicosatetraenoic acid attenuates the development of diabetes-induced vascular dysfunction in the rat carotid artery.
    Pharmacological research, 2005, Volume: 52, Issue:3

    Topics: Amidines; Animals; Benzylamines; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Calcium-Calmodulin-Dependent Protein Kinases; Carotid Arteries; Carotid Artery Diseases; Diabetes Mellitus, Experimental; Hydroxyeicosatetraenoic Acids; Monomeric GTP-Binding Proteins; Organophosphonates; Protein Kinase Inhibitors; Rats; Rats, Wistar; Streptozocin; Sulfonamides; Triazoles; Vascular Diseases; Vasoconstriction; Vasodilation

2005